NLS Uncategorized

Scientists at deCODE genetics have together with their Nordic collaborators published the largest genome-wide association study to date on rheumatoid arthritis (RA), including over thirty thousand cases and one million controls. The study is based on an extensive collaboration between researchers in six northwestern European countries and includes information on not only RA overall but […]

OligoNova, Sweden’s national initiative for oligonucleotide therapies, is gathering leading Swedish oligonucleotide experts for its first face-to-face network conference. The conference is to be held at GoCo Health innovation City in Mölndal on April 25-26, 2022. The primary aims of this gathering of researchers, clinicians and innovators, representing approximately 40 research groups from across Swedish […]

Elicera Therapeutics have announced the publication of a scientific article describing the mechanism-of-action of the company’s universal CAR T-cell enhancement technology platform iTANK in Nature Biomedical Engineering. Proof-of-concept data presented in the publication also indicate that the iTANK-platform is universally compatible with other CAR T-cell therapies, states the company in a press release. The iTANK-platform […]

Between 2009 and 2019, the number of life science companies in the Stockholm-Uppsala region increased by almost 50%. This is stated in a report published by the Stockholm Science City Foundation on the 31 of March. Half of the employees within Sweden’s life science work in the region, which means 31,500 people at nearly 1,000 […]

Swedish startup Acorai’s vision is to transform heart failure management, and during 2022 the company will have the opportunity to accelerate their solution on the French market. In July 2021 EIT Health launched a new joint accelerator program for Swedish start-ups in digital health and artificial intelligence (AI). At the inauguration of the accelerator program […]

The largest genetic study of migraine to date reveals new genetic risk factors. In the largest genome study of migraine yet, researchers have more than tripled the number of known genetic risk factors for migraine. Among the identified 123 genetic regions are two that contain target genes of recently developed migraine-specific drugs. The study involved […]